Key points are not available for this paper at this time.
In large multinational clinical therapeutic trials, responses in one region can differ from those in another. This article examines reasons for such differences and suggests criteria for determining whether the differences are real or the play of chance.
Yusuf et al. (Wed,) studied this question.